# US 2023/0273455 A1 · Optically active devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0273455 A1
- Document ID: US20230273455A1
- Status: Published application
- Kind: A1
- Application number: 18/005,600
- Filed: 2021-05-07
- Published: 2023-08-31
- Earliest claimed: 2020-07-15
- Applicants: Johnson & Johnson Surgical Vision, Inc.
- Inventors: David MOORE; Lars DOBELMANN-MARA; Sarah HAHNEBACH; Philipp HOFMANN; Martin SCHRAUB
- Web page: https://patentgrep.com/patent/US20230273455A1

## CPC

- G02B 1/043: {Contact lenses}
- G02C 7/022: {Ophthalmic lenses having special refractive features achieved by special materials or material structures (G02C7/049 takes precedence)}
- C07D 239/10: Oxygen or sulfur atoms
- C07D 309/06: Radicals substituted by oxygen atoms
- G03F 7/027: Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds (G03F7/075 takes precedence)
- G02B: OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02C: SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES (trial frames for testing the eyes A61B3/04; goggles or eyeshields not having the same features as spectacles A61F9/00)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- G03F: PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR; (phototypographic composing devices B41B; photosensitive materials or processes for photographic purposes G03C; electrophotography, sensitive layers or processes therefor G03G)

## Abstract

The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive chromophore, said polymerized compounds, and special monomer compounds being particularly suitable for compositions and ophthalmic devices. The present invention is also directed to a process of changing the optical properties of said ophthalmic device or a precursor article for manufacturing an ophthalmic device.

## Claims

### Claim 1

An ophthalmic device or a precursor article for manufacturing an ophthalmic device comprising at least one polymerized compound of formula (I) or formula (II)
wherein
Y0, Y1 are each independently of each other O or S;
X is absent or C═O;
R1 is a trialkoxysilyl group or a dialkoxyalkylsilyl group where the alkyl and/or alkoxy groups are each independently linear or branched having 1 to 6 C atoms, or a silyl group of formula (1), (2) or (3) or a polymerizable group of formula (4),
where alkyl means at each occurrence independently of each other a linear or branched alkyl group having 1 to 6 C atoms and the asterisk “*” denotes at each occurrence independently of each other a linkage to the linker [L];
and wherein
X11 is selected from the group consisting of O, S, O—SO2, SO2—O, C(═O), OC(═O), C(═O)O, S(C═O) and (C═O)S,
R5, R6, R7 are at each occurrence independently of each other selected from the group consisting of H, F, a linear or branched, non-fluorinated, partially or completely fluorinated alkyl group having 1 to 20 C atoms and aryl with 6 to 14 C atoms and
c is 0 or 1;
[L] is —(C(R)2)o—, or —(C(R)2)p—X8—(C(R)2)q—(X9)s-(C(R)2)r—(X10)t—(C(R)2)u—;
R is at each occurrence independently selected from the group consisting of H, F, a linear or branched alkyl group having 1 to 4 C atoms or a linear or branched partially or fully fluorinated alkyl group having 1 to 4 C atoms;
o is selected from the group consisting of 1 to 20,
X8, X9, X10 are at each occurrence independently O, S, SO2, or NR0,
s, t is 0 or 1,
p, q are at each occurrence independently selected from the group consisting of 1 to 10,
r, u are at each occurrence independently selected from the group consisting of 0 to 10, wherein the overall number of atoms for —(C(R)2)p—X8—(C(R)2)q—(X9)s-(C(R)2)r—(X10)t—(C(R)2)u— is up to 20 atoms,
R0 is at each occurrence independently selected from the group consisting of a linear or branched alkyl group having 1 to 4 C atoms and a linear or branched partially or fully fluorinated alkyl group having 1 to 4 C atoms;
R2 is at each occurrence independently of each other H, a linear or branched, non-halogenated, partially or completely halogenated alkyl group having 1 to 20 C atoms, a cycloalkyl group having 3 to 7 C atoms, or a non-halogenated, partially or completely halogenated aryl group with 6 to 14 C atoms which may be substituted by one or more R′;
R2 and R4 may also form a mono- or polycyclic aliphatic or aromatic ring system with each other;
R3, R4 are at each occurrence independently of each other H, F, Cl, Br, CN, a linear or branched, non-halogenated, partially or completely halogenated alkyl group having 1 to 20 C atoms, a linear or branched, non-halogenated, partially or completely halogenated alkoxy group having 1 to 20 C atoms, a linear or branched, non-halogenated, partially or completely halogenated thioalkyl group having 1 to 20 C atoms, or a non-halogenated, partially or completely halogenated aryl group with 6 to 14 C atoms which may be substituted by one or more R′;
R′ is at each occurrence independently selected from the group consisting of SF5, CN, SO2CF3, a linear or branched, non-halogenated, partially or completely halogenated alkyl group having 1 to 20 C atoms, a non-halogenated, partially or completely halogenated cycloalkyl group having 3 to 6 C atoms, a linear or branched, non-halogenated, partially or completely halogenated alkoxy group having 1 to 20 C atoms and a linear or branched, non-halogenated, partially or completely halogenated thioalkyl group having 1 to 20 C atoms.

### Claim 2 (depends on 1)

The ophthalmic device or the precursor article for manufacturing an ophthalmic device according to claim 1 wherein in polymerized compounds of formula (I) or formula (II), X is absent.

### Claim 3 (depends on 1)

The ophthalmic device or the precursor article for manufacturing an ophthalmic device according to claim 1 wherein in polymerized compounds of formula (I) or formula (II), [L] is —(C(R)2)o— and o is 1 to 20.

### Claim 4 (depends on 1)

The ophthalmic device or the precursor article for manufacturing an ophthalmic device according to claim 1 comprising an oligomer, polymer or copolymer comprising a constitutional unit M0 based on formulae (I) or (II) where R1 on each occurrence is polymerized, R1 thus forms the regioregular, alternated, regiorandom, statistical, block or random oligomer or polymer backbone or is part of the copolymer backbone.

### Claim 5 (depends on 1)

The ophthalmic device or the precursor article for manufacturing an ophthalmic device according to claim 1 where said polymerized group R1 is of formulae (1-p), (2-p), (3-p) or (4−p)
where the asterisk “*” within formulae (1-p) to (4-p) denotes a linkage to the adjacent repeating unit in the polymer chain or oligomer chain or to a terminal end group, the asterisk “**” within formulae (1-p) to (4-p) denotes the linkage to the remainder of formulae (I) or (II) and R5, R6, R7, X11 and c has a meaning according to claim 1.

### Claim 6 (depends on 1)

The ophthalmic device or the precursor article for manufacturing an ophthalmic device according to claim 1 wherein polymerized R1 is at each occurrence independently derived from an acryl or methacryl radical.

### Claim 7 (depends on 1)

The ophthalmic device or the precursor article for manufacturing an ophthalmic device according to claim 1 wherein the constitutional unit M0 is of formulae (M0-I) or (M0-II),
where X, Y0, Y1, [L], R2, R3, R4, R5, R6, R7, X11 and c have a meaning according to any preceding claim and where the asterisk “*” denotes at each occurrence a linkage to the adjacent repeating unit in the polymer chain or oligomer chain or to a terminal end group.

### Claim 8 (depends on 1)

The ophthalmic device or the precursor article for manufacturing an ophthalmic device according to claim 1 comprising beside of the at least one polymerized compound of formulae (I) or (II) or the constitutional unit M0 of formulae (M0-I) or (M0-II) at least one further polymerized monomer selected from the group consisting of styrene, ethoxyethyl methacrylate (EOEMA), methyl methacrylate (MMA), methyl acrylate, n-alkyl acrylates (the n-alkyl group comprising 2-20 C-atoms), n-alkyl methacrylates (the n-alkyl group comprising 2-20 C-atoms), i-alkyl acrylates (the i-alkyl group comprising 3-20 C-atoms), i-alkyl methacrylates (the i-alkyl group comprising 3-20 C-atoms), ethoxyethoxy ethylacrylate (EEEA), n-hydroxalkyl acrylate (the n-alkyl group comprising 2 to 10 C-atoms), n-hydroxalkyl methacrylate (the n-alkyl group comprising 2 to 10 C-atoms), tetrahydrofuryl methacrylate (THFMA), glycidylmethacrylate (GMA), 16-hydroxyhexadecyl acrylate, 16-hydroxyhexadecyl methacrylate, 18-hydroxyoctadecyl acrylate, 18-hydroxyoctadecyl methacrylate, 2-phenoxyethyl acrylate (EGPEA), heptafluorobutyl acrylate, heptafluorobutyl methacrylate, hexafluorobutyl acrylate, hexafluorobutyl methacrylate, hexafluoroisopropyl acrylate, hexafluoroisopropyle methacrylate, octafluoropentyl acrylate, octafluoropentyl methacrylate, petanfluoropropyl acrylate, pentafluoropropyl methacrylate, tetrafluoropropyl methacrylate, trifluoroethyl acrylate, trifluoroethyl methacrylate.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6)

Process of forming an ophthalmic device or a precursor article for manufacturing an ophthalmic device according to claim 1, said process comprising the steps of
providing a composition comprising at least one compound of formulae (I) or (II) as described in one or more of claims 1 to 6 and/or an oligomer, polymer or copolymer comprising at least one polymerized compound of formulae (I) or (II) as described in one or more of claims 1 to 6 but having at least one reactive group left for polymerization and optionally further monomers different from compounds of formulae (I) or (II) and/or crosslinking agents and/or UV absorbers and/or radical initiators;
subsequently forming the ophthalmic device or precursor article of said composition.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

Process of changing the optical properties of an ophthalmic device or a precursor article for manufacturing an ophthalmic device according to claim 1, said process comprising the steps of
providing an ophthalmic device or a precursor article according to one or more of claims 1 to 8, and
subsequently exposing said ophthalmic device or precursor article to irradiation having a wavelength of at least 200 nm and at most 1500 nm.

### Claim 11 (depends on 10)

Ophthalmic device or precursor article for manufacturing an ophthalmic device obtainable by the process according to claim 10.

### Claim 12 (depends on 1)

Oligomer, polymer or copolymer comprising at least one polymerized compound of formulae (I) or (II) wherein at least one of Y0 and Y1 is S as described in claim 1 provided that silicates are excluded.

### Claim 13 (depends on 12)

Oligomer, polymer or copolymer according to claim 12 comprising beside of the polymerized compound(s) of formulae (I) or (II) wherein at least one of Y0 and Y1 is S at least one further polymerized monomer selected from the group consisting of styrene, ethoxyethyl methacrylate (EOEMA), methyl methacrylate (MMA), methyl acrylate, n-alkyl acrylates (the n-alkyl group comprising 2-20 C-atoms), n-alkyl methacrylates (the n-alkyl group comprising 2-20 C-atoms), i-alkyl acrylates (the i-alkyl group comprising 3-20 C-atoms), i-alkyl methacrylates (the i-alkyl group comprising 3-20 C-atoms), ethoxyethoxy ethylacrylate (EEEA), n-hydroxalkyl acrylate (the n-alkyl group comprising 2 to 10 C-atoms), n-hydroxalkyl methacrylate (the n-alkyl group comprising 2 to 10 C-atoms), tetrahydrofuryl methacrylate (THFMA), glycidylmethacrylate (GMA), 16-hydroxyhexadecyl acrylate, 16-hydroxyhexadecyl methacrylate, 18-hydroxyoctadecyl acrylate, 18-hydroxyoctadecyl methacrylate, 2-phenoxyethyl acrylate (EGPEA), heptafluorobutyl acrylate, heptafluorobutyl methacrylate, hexafluorobutyl acrylate, hexafluorobutyl methacrylate, hexafluoroisopropyl acrylate, hexafluoroisopropyle methacrylate, octafluoropentyl acrylate, octafluoropentyl methacrylate, petanfluoropropyl acrylate, pentafluoropropyl methacrylate, tetrafluoropropyl methacrylate, trifluoroethyl acrylate, trifluoroethyl methacrylate.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6)

Composition for polymerization comprising at least one compound of formulae (I) or (II) wherein at least one of Y0 and Y1 is S as described in claim 1 and a polymerization initiator and optionally a UV absorber and/or a crosslinking agent and/or further monomers different from compounds of formulae (I) or (II) as described in one of claims 1 to 6.

### Claim 15

Compounds of formulae (I) and (II)
wherein
Y0, Y1 are each independently of each other O or S but at least one of Y0 or Y1 is S;
X is absent or C═O;
R1 is a trialkoxysilyl group or a dialkoxyalkylsilyl group where the alkyl and/or alkoxy groups are each independently linear or branched having 1 to 6 C atoms, or a silyl group of formula (1), (2) or (3) or a polymerizable group of formula (4),
where alkyl means at each occurrence independently of each other a linear or branched alkyl group having 1 to 6 C atoms and the asterisk “*” denotes at each occurrence independently of each other a linkage to the linker [L];
and wherein
X11 is selected from the group consisting of O, S, O—SO2, SO2—O, C(═O), OC(═O), C(═O)O, S(C═O) and (C═O)S,
R5, R6, R7 are at each occurrence independently of each other selected from the group consisting of H, F, a linear or branched, non-fluorinated, partially or completely fluorinated alkyl group having 1 to 20 C atoms and aryl with 6 to 14 C atoms and
c is 1;
[L] is —(C(R)2)o—, or —(C(R)2)p—X8—(C(R)2)q—(X9)s-(C(R)2)r—(X10)t—(C(R)2)u—;
R is at each occurrence independently selected from the group consisting of H, F, a linear or branched alkyl group having 1 to 4 C atoms or a linear or branched partially or fully fluorinated alkyl group having 1 to 4 C atoms;
o is selected from the group consisting of 1 to 20,
X8, X9, X10 are at each occurrence independently 0, S, SO2, or NR0,
s, t is 0 or 1,
p, q are at each occurrence independently selected from the group consisting of 1 to 10,
r, u are at each occurrence independently selected from the group consisting of 0 to 10, wherein the overall number of atoms for —(C(R)2)p—X8—(C(R)2)q—(X9)s-(C(R)2)r—(X10)t—(C(R)2)u— is up to 20 atoms,
R0 is at each occurrence independently selected from the group consisting of a linear or branched alkyl group having 1 to 4 C atoms and a linear or branched partially or fully fluorinated alkyl group having 1 to 4 C atoms;
R2 is at each occurrence independently of each other H, a linear or branched, non-halogenated, partially or completely halogenated alkyl group having 1 to 20 C atoms, a cycloalkyl group having 3 to 7 C atoms, or a non-halogenated, partially or completely halogenated aryl group with 6 to 14 C atoms which may be substituted by one or more R′;
R2 and R4 may also form a mono- or polycyclic aliphatic or aromatic ring system with each other;
R3, R4 are at each occurrence independently of each other H, F, Cl, Br, CN, a linear or branched, non-halogenated, partially or completely halogenated alkyl group having 1 to 20 C atoms, a linear or branched, non-halogenated, partially or completely halogenated alkoxy group having 1 to 20 C atoms, a linear or branched, non-halogenated, partially or completely halogenated thioalkyl group having 1 to 20 C atoms, or a non-halogenated, partially or completely halogenated aryl group with 6 to 14 C atoms which may be substituted by one or more R′;
R′ is at each occurrence independently selected from the group consisting of SF5, CN, SO2CF3, a linear or branched, non-halogenated, partially or completely halogenated alkyl group having 1 to 20 C atoms, a non-halogenated, partially or completely halogenated cycloalkyl group having 3 to 6 C atoms, a linear or branched, non-halogenated, partially or completely halogenated alkoxy group having 1 to 20 C atoms and a linear or branched, non-halogenated, partially or completely halogenated thioalkyl group having 1 to 20 C atoms.

### Claim 16

Compounds of formulae (1) and (II)
wherein
Y0, Y1 are each 0;
X is absent or C═O;
R1 is a trialkoxysilyl group or a dialkoxyalkylsilyl group where the alkyl and/or alkoxy groups are each independently linear or branched having 1 to 6 C atoms, or a silyl group of formula (1), (2) or (3) or a polymerizable group of formula (4),
where alkyl means at each occurrence independently of each other a linear or branched alkyl group having 1 to 6 C atoms and the asterisk “*” denotes at each occurrence independently of each other a linkage to the linker [L];
and wherein
X11 is selected from the group consisting of O, S, O—SO2, SO2—O, C(═O), OC(═O), C(═O)O, S(C═O) and (C═O)S,
R5, R6, R7 are at each occurrence independently of each other selected from the group consisting of H, F, a linear or branched, non-fluorinated, partially or completely fluorinated alkyl group having 1 to 20 C atoms and aryl with 6 to 14 C atoms and
c is 1;
[L] is —(C(R)2)o—, or —(C(R)2)p—X8—(C(R)2)q—(X9)s-(C(R)2)r—(X10)t—(C(R)2)u—;
R is at each occurrence independently selected from the group consisting of H, F, a linear or branched alkyl group having 1 to 4 C atoms or a linear or branched partially or fully fluorinated alkyl group having 1 to 4 C atoms;
o is selected from the group consisting of 5 to 20,
X8, X9, X10 are at each occurrence independently 0, S, SO2, or NR0,
s, t is 0 or 1,
p, q are at each occurrence independently selected from the group consisting of 1 to 10,
r, u are at each occurrence independently selected from the group consisting of 0 to 10, wherein the overall number of atoms for —(C(R)2)p—X8—(C(R)2)q—(X9)s-(C(R)2)r—(X10)t—(C(R)2)u— is up to 20 atoms, R0 is at each occurrence independently selected from the group consisting of a linear or branched alkyl group having 1 to 4 C atoms and a linear or branched partially or fully fluorinated alkyl group having 1 to 4 C atoms;
R2 is at each occurrence independently of each other H, a linear or branched, non-halogenated, partially or completely halogenated alkyl group having 1 to 20 C atoms, a cycloalkyl group having 3 to 7 C atoms, or a non-halogenated, partially or completely halogenated aryl group with 6 to 14 C atoms which may be substituted by one or more R′;
R2 and R4 may also form a mono- or polycyclic aliphatic or aromatic ring system with each other;
R3, R4 are at each occurrence independently of each other H, F, Cl, Br, CN, a linear or branched, non-halogenated, partially or completely halogenated alkyl group having 1 to 20 C atoms, a linear or branched, non-halogenated, partially or completely halogenated alkoxy group having 1 to 20 C atoms, a linear or branched, non-halogenated, partially or completely halogenated thioalkyl group having 1 to 20 C atoms, or a non-halogenated, partially or completely halogenated aryl group with 6 to 14 C atoms which may be substituted by one or more R′;
R′ is at each occurrence independently selected from the group consisting of SF5, CN, SO2CF3, a linear or branched, non-halogenated, partially or completely halogenated alkyl group having 1 to 20 C atoms, a non-halogenated, partially or completely halogenated cycloalkyl group having 3 to 6 C atoms, a linear or branched, non-halogenated, partially or completely halogenated alkoxy group having 1 to 20 C atoms and a linear or branched, non-halogenated, partially or completely halogenated thioalkyl group having 1 to 20 C atoms.
